Subscribe
  • Home
  • Issues
    • Latest Issue
    • Issue Archive
    • Special Issues
      • 2022 Midyear Review: Non–Small-Cell Lung Cancer
      • 2022 Oncology Biosimilar Guide to Patient Support Services
      • 2022 Breast Cancer Guide to Patient Support Services
  • Browse By Topic
    • Practice Management
    • Financial Management
    • Reimbursement
    • Health Policy
    • Quality Care
    • ICD Codes
    • Survivorship
    • FDA Approvals, News & Updates
    • In the News
  • Guide to Patient Support Services
    • Index
    • Introduction
    • 2023 Spotlight
  • Conference Correspondent
    • ASCO 2022 - Wrap Up
    • NSCLC IO 2022 - Midyear Review
    • SABCS 2021 Wrap-Up
    • Dual IO 2021 Year in Review
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Webinars
    • Rapid Reactions
    • In the News
    • Quick Quiz
    • Multiple Myeloma Monthly Minutes
    • Melanoma Monthly Minutes
    • Press Releases
    • Women's Health Monthly Minutes
    • Lung Cancer Monthly Minutes
    • Gastrointestinal Cancer Monthly Minutes
  • Issues
  • 2014
  • June 2014, Vol 4, No 4

June 2014, Vol 4, No 4

Imbruvica (Ibrutinib) the First Bruton’s Tyrosine Kinase Inhibitor Approved for the Treatment of Patients with Relapsed Chronic Lymphocytic Leukemia
By Lisa A. Raedler, PhD, RPh
Drug Updates
Read More ›

Imbruvica YOU&i Access Program and Support for Patients
Read More ›

Providing Social Support to Patients with Cancer
Practice Management
Read More ›

ICD-9 or ICD-10: What Is the Point?
By Karna W. Morrow, CPC, RCC, CCS-P, PCS
Coding and Billing, Reimbursement
Regardless of which version you are considering, the International Classification of Diseases, Clinical Modification (ICD-CM) is a morbidity classification published by the United States for classifying diagnoses and reasons for visits in all healthcare settings. Read More ›

Shopping for High-Quality, Affordable Oncology Care
By Carla Balch, CEO
Quality Care
Read More ›

Drug Compounding: New Rule a Game Changer for Oncology Practices
By Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
Read More ›

Fair Labor Standards Act: Exemptions Review
By Robert D. Orzechowski, MBA, SPHR, SHRM-SCP
Read More ›

Do’s and Don’ts in Physician-Hospital Alignment, Part 1
By Max Reiboldt, CPA
Practice Management
Read More ›

FDA-Approved Medications Used for the Treatment of Lung Cancer
ICD Codes
Read More ›

New Clinical Trials Under Way
Clinical Trials Tracker
Read More ›

View the Latest Issue of OPM
View the Latest Issue
Read Issue

Top Trending Articles

1.
Specialty Carve-Outs: What Are the Implications for Patients and Practices?
By Dawn Holcombe, MBA, FACMPE, ACHE
2.
2023 Spotlight: Amgen
3.
New Policies Regarding Intravenous Iron Replacement Are Creating Conundrum for Providers and Payers
By Dawn Holcombe, MBA, FACMPE, ACHE
  • Home
  • Issues
    • Latest Issue
    • Issue Archive
    • Special Issues
      • 2022 Midyear Review: Non–Small-Cell Lung Cancer
      • 2022 Oncology Biosimilar Guide to Patient Support Services
      • 2022 Breast Cancer Guide to Patient Support Services
  • Browse By Topic
    • Practice Management
    • Financial Management
    • Reimbursement
    • Health Policy
    • Quality Care
    • ICD Codes
    • Survivorship
    • FDA Approvals, News & Updates
    • In the News
  • Guide to Patient Support Services
    • Index
    • Introduction
    • 2023 Spotlight
  • Conference Correspondent
    • ASCO 2022 - Wrap Up
    • NSCLC IO 2022 - Midyear Review
    • SABCS 2021 Wrap-Up
    • Dual IO 2021 Year in Review
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Webinars
    • Rapid Reactions
    • In the News
    • Quick Quiz
    • Multiple Myeloma Monthly Minutes
    • Melanoma Monthly Minutes
    • Press Releases
    • Women's Health Monthly Minutes
    • Lung Cancer Monthly Minutes
    • Gastrointestinal Cancer Monthly Minutes
CONNECT
Subscribe
  • About
    • About OPM
    • Mission Statement
    • Editorial Board
    • AOPM
    • Contact
  • Contribute
    • Submit a Manuscript
    • Author Guidelines
  • Connect
    • Join Us on LinkedIn
Sign Up for Oncology News

Subscribe to recieve the free, monthly OPM print publication and OPM weekly e‑newsletter.

Subscribe
© The Lynx Group, LLC. All Rights Reserved. Privacy Policy.